| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.005 |